Skip to main content
SpringerLink
Log in

Proposed universal definitions for drug safety terminology based on existing ones

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV
Table V

References

  1. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005: 28(10): 851–70

    Article  PubMed  Google Scholar 

  2. World Health Organization. International drug monitoring: the role of national centres. Technical Report Series No 498. Geneva: WHO, 1972

  3. Hartigan-Go KY, Wong JQ. Inclusion of therapeutic failures as adverse drug reactions. In: Aronson JK, editor. Side effects of drugs. Annual 23. Amsterdam: Elsevier, 2000: xxvii–xxxiii

  4. Rawlins MD. Clinical pharmacology: adverse reactions to drugs. BMJ (Clin Res Ed) 1981; 282: 974–6

    Article  CAS  Google Scholar 

  5. Rawlins MD, Thomas SHL. Mechanisms of adverse drug reactions. In: Davies DM, Ferner RE, De Glanville H, editors. Davies’s textbook of adverse drug reactions. 5th ed. London: Chapman & Hall Medical, 1998: 40

    Google Scholar 

  6. Grahame-Smith DG, Aronson JK. The Oxford textbook of clinical pharmacology and drug therapy. Oxford: Oxford University Press, 1984: 134

    Google Scholar 

  7. Park BK, Pirmohamed M, Kitteringham NR. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 1992; 34: 377–95

    Article  PubMed  CAS  Google Scholar 

  8. Laurence DR, Bennett PN. Clinical pharmacology. Edinburgh: Churchill Livingstone, 1992: 121-2

    Google Scholar 

  9. Ferner R, Mann RD. Drug safety and pharmacovigilance. In: Page C, Curtis MJ, Sutter MC, et al., editors. Integrated pharmacology. 1st ed. London: Mosby, 1997: 83–90

    Google Scholar 

  10. Aronson JK, Ferner RE. Joining the DoTS: classifying adverse drug reactions by dose responsiveness, time course, and susceptibility. BMJ 2003; 327: 1222–5

    Article  PubMed  CAS  Google Scholar 

  11. Meyboom RHB, Royer RJ. Causality classification at pharmacovigilance centres in the European Community. Pharmacoepidemiol Drug Saf 1992; 1: 87–97

    Article  Google Scholar 

  12. Bryant GD, Norman GR. Expressions of probability: words and numbers [letter]. N Engl J Med 1980; 302: 411

    PubMed  CAS  Google Scholar 

  13. Kong A, Barnett GO, Mosteller F, et al. How medical professionals evaluate expressions of probability. N Engl J Med 1986; 315: 740–4

    Article  PubMed  CAS  Google Scholar 

  14. Roberts DE, Gupta G. How medical professionals evaluate expressions of probability [letter]. N Engl J Med 1987; 316: 550

    Google Scholar 

  15. Mapes REA. Verbal and numerical estimates of probability in therapeutic contexts. Soc Sci Med 1979; 13A: 277–82

    PubMed  CAS  Google Scholar 

  16. Calman KC. Cancer: science and society and the communication of risk. BMJ 1996; 313: 799–802

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Proposed universal definitions for drug safety terminology based on existing ones. Drugs Ther. Perspect 22, 22–26 (2006). https://doi.org/10.2165/00042310-200622070-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200622070-00008

Search

Navigation